Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Concurrent Session 7: Regulatory Aspects of Drug Development: Safety, Efficacy, and Beyond

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Development and Regulation of New Drugs in Targeted Subgroups
Dr. Jaap Verweij
Erasmus University Medical Center, Rotterdam, The Netherlands
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
The Revised European Guidelines for Anticancer Drug Development
Dr. Patrick Therasse
EORTC Data Center, Brussels, Belgium
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
Recent Guidance on Early Drug Development
Dr. Jerry M. Collins
Food & Drug Administration, Rockville, MD
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
Report on Workshops Dedicated to Endpoints in Cancer Clinical Trials
Dr. Ramzi N. Dagher
Food & Drug Administration, Rockville, MD
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4